Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
St. John's Wort and Kava for MDD with Anxiety
NCT00451516Phase 2Completed
- Sponsor
- The University of Queensland
- Start
- Mar 2007
- Primary completion
- Oct 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in major depressive disorder (MDD) and anxiety disorder comparing St. John's Wort + Kava with Placebo (2 arms). Primary endpoints: Beck Depression Inventory II, Beck Anxiety Inventory and 1 more. Started Mar 2007; status: completed.
02
Drugs
hypericum perforatumkava
03
Conditions
major depressive disorder (MDD)anxiety disorder
Beyond the preview
Go deeper on NCT00451516.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00451516.